Guest Blogs
-
New Approaches To Antifungal Therapies Hope To Push New Drugs To Market In The Near Future
8/2/2021
Millions of fungal species live in soil, grow on plants, not to mention on our bodies. Every inhalation can introduce fungal spores. To find out how this happens, read the available blog post.
-
Gene Therapy Startup Uses Horses To Test Possible Osteoarthritis Therapy
8/2/2021
Osteoarthritis is a debilitating and painful wearing down of joint cartilage tissues. Every year, more than three million people in the U.S. (and millions more worldwide) are diagnosed with the disease. Read the available blog to find out more.
-
New Eye Color Genetics Research Could Revolutionize Eye Disease Treatment
8/2/2021
A new study cited in Science Daily suggests that the genetics of human eye color may be much more complex than previously thought. Interestingly, this study could have implications that go far beyond eye color.
-
Back To The Egg — Searching For A Low-Cost COVID-19 Vaccine
8/2/2021
For developing countries where there is limited access to vaccines, COVID-19 infection rates are an ongoing concern. Read the available blog post to find out more.
-
A New Malaria Vaccine Showing High Efficacy Rate Could Be Available Soon
8/2/2021
Malaria has long been one of the most threatening diseases in the tropical world. About 229 million cases were recorded in 2019, and 409,000 deaths, according to the World Health Organization (WHO). Read about how an effective malaria vaccine came to be.
-
A CRO's Way Forward In The Midst Of A Pandemic: QPS Operations And COVID-19
6/18/2021
In this Q&A, QPS Holdings LLC Chairman President, and CEO, Ben Chien, Ph.D., reflects on the progress of the company’s growth from a small, three-person start-up to a mid-sized CRO, the impact COVID-19 has had on drug development and clinical trials, and the way forward for CROs in the midst of a pandemic.
-
11 Guidelines For Responsible Clinical Use Of Human Genome Editing
6/18/2021
A common refrain in science fiction movies is the cautionary statement, “Just because we can doesn’t mean we should.” As new technologies such as CRISPR/Cas9 have made gene editing at precise locations in DNA possible, that sentiment has plagued ethicists and scientists alike regarding heritable human genomes.
-
The Most Effective COVID-19 Vaccine Could Be Intranasal
6/17/2021
Vaccine developers are looking at preventing the coronavirus from being transmitted by focusing on the nose and respiratory tract. An intranasal vaccine would trigger immune responses in the nose, throat and lung mucosa by targeting immunoglobulin A (IgA), antibodies which exist solely in the mucosa. The mucosa acts as a physical barrier to potential pathogens, trapping them before they have a chance to enter the body. Given this, the intranasal vaccine would prevent transmission from exhaled droplets or aerosols, as there would not be virus in the body to exhale.
-
Covid-19 And Brain Fog: How Some Infections Affect The Neurological System
6/17/2021
Difficulty thinking, concentrating, and remembering are amongst the most debilitating long-haul symptoms of COVID-19. In some cases, this “brain fog” can linger for months. New research helps explain how SARS-CoV-2, the virus that causes COVID-19, spreads to the brain and why some patients experience severe neurological symptoms while others do not.
-
How COVID-19 Has Impacted Clinical Trials
6/17/2021
Social distancing. Country-wide lockdowns. Mask mandates. In the last year, people around the world have been forced to adapt their everyday lives to mitigate the spread of COVID-19 – and the clinical trial community is no exception. This article explores ways that clinical trial teams have modified clinical trial management since the advent of the pandemic and how these alterations influence the future of clinical research.